452 related articles for article (PubMed ID: 15353558)
21. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
[TBL] [Abstract][Full Text] [Related]
22. Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh.
Wall NR; Mohammad RM; Al-Katib AM
Cell Growth Differ; 2001 Dec; 12(12):641-7. PubMed ID: 11751459
[TBL] [Abstract][Full Text] [Related]
23. MEK inhibitors impair insulin-stimulated glucose uptake in 3T3-L1 adipocytes.
Harmon AW; Paul DS; Patel YM
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E758-66. PubMed ID: 15172888
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-1beta induces MUC2 gene expression and mucin secretion via activation of PKC-MEK/ERK, and PI3K in human airway epithelial cells.
Kim YD; Jeon JY; Woo HJ; Lee JC; Chung JH; Song SY; Yoon SK; Baek SH
J Korean Med Sci; 2002 Dec; 17(6):765-71. PubMed ID: 12482999
[TBL] [Abstract][Full Text] [Related]
25. The PLC-PKC cascade is required for IL-1beta-dependent Erk and Akt activation: their role in proliferation.
Amin AR; Ichigotani Y; Oo ML; Biswas MH; Yuan H; Huang P; Mon NN; Hamaguchi M
Int J Oncol; 2003 Dec; 23(6):1727-31. PubMed ID: 14612947
[TBL] [Abstract][Full Text] [Related]
26. 4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D and E and cyclin-dependent kinase inhibitor p27kip1.
Lee HW; Nam KO; Park SJ; Kwon BS
Eur J Immunol; 2003 Aug; 33(8):2133-41. PubMed ID: 12884287
[TBL] [Abstract][Full Text] [Related]
27. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
28. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.
Milella M; Kornblau SM; Estrov Z; Carter BZ; Lapillonne H; Harris D; Konopleva M; Zhao S; Estey E; Andreeff M
J Clin Invest; 2001 Sep; 108(6):851-9. PubMed ID: 11560954
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation.
Shelton JG; Moye PW; Steelman LS; Blalock WL; Lee JT; Franklin RA; McMahon M; McCubrey JA
Leukemia; 2003 Sep; 17(9):1765-82. PubMed ID: 12970777
[TBL] [Abstract][Full Text] [Related]
31. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB.
Mirza AM; Kohn AD; Roth RA; McMahon M
Cell Growth Differ; 2000 Jun; 11(6):279-92. PubMed ID: 10910095
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
34. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
[TBL] [Abstract][Full Text] [Related]
35. Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.
Motti ML; Califano D; Troncone G; De Marco C; Migliaccio I; Palmieri E; Pezzullo L; Palombini L; Fusco A; Viglietto G
Am J Pathol; 2005 Mar; 166(3):737-49. PubMed ID: 15743786
[TBL] [Abstract][Full Text] [Related]
36. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
37. Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia.
Minami Y; Yamamoto K; Kiyoi H; Ueda R; Saito H; Naoe T
Blood; 2003 Oct; 102(8):2969-75. PubMed ID: 12842996
[TBL] [Abstract][Full Text] [Related]
38. EGF stimulates mesangial cell mitogenesis via PI3-kinase-mediated MAPK-dependent and AKT kinase-independent manner: involvement of c-fos and p27Kip1.
Mahimainathan L; Ghosh-Choudhury N; Venkatesan BA; Danda RS; Choudhury GG
Am J Physiol Renal Physiol; 2005 Jul; 289(1):F72-82. PubMed ID: 15701816
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells.
Yu XD; Wang SY; Chen GA; Hou CM; Zhao M; Hong JA; Nguyen DM; Schrump DS
Cancer J; 2007; 13(2):105-13. PubMed ID: 17476138
[TBL] [Abstract][Full Text] [Related]
40. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
